Please enable JavaScript to continue using this application.

Compare $CMPX vs $DTIL | Chartloom

Compare

$CMPX vs $DTIL

Compass Therapeutics Inc. · Precision BioSciences Inc

CMPX

Compass Therapeutics Inc.

DTIL

Precision BioSciences Inc

Compare $CMPX vs $DTIL

Comparing Compass Therapeutics Inc. and Precision BioSciences Inc

CMPXCompass Therapeutics Inc.

DTILPrecision BioSciences Inc

CMPXCompass Therapeutics Inc.

Market cap

$179M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.51x

Rev growth (TTM)

—

YTD performance

-80.8%

52W performance

-74.5%

FCF yield

-31.5%

DTILPrecision BioSciences Inc

Market cap

$173M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

80.94x

Rev growth (TTM)

3473.0%

YTD performance

63.9%

52W performance

17.9%

FCF yield

-30.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CMPX

DTIL

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

DTIL

Precision BioSciences Inc

Market Cap

CMPX$179M

DTIL$173M

Enterprise Value

CMPX$143M

DTIL$110M

Price

CMPX$0.99

DTIL$6.72

P/E Ratio

CMPXN/A

DTILN/A

P/S Ratio

CMPX0.00x

DTIL3.85x

EV/Sales

CMPX0.00x

DTIL2.44x

EV/EBITDA

CMPX0.00x

DTIL0.00x

P/B Ratio

CMPX0.93x

DTIL3.85x

P/FCF Ratio

CMPXN/A

DTILN/A

EV/FCF

CMPX-2.54x

DTIL-2.09x

PEG Ratio

CMPXN/A

DTILN/A

Forward P/E (NTM)

CMPXN/A

DTILN/A

Forward P/S (NTM)

CMPX1.51x

DTIL80.94x

Revenue (TTM)

CMPX$0

DTIL$45M

Revenue Growth (YoY)

CMPXN/A

DTIL3473.0%

Forward Rev Growth

CMPX397.5%

DTIL-28.2%

Gross Margin (TTM)

CMPX0.0%

DTIL0.0%

Operating Margin (TTM)

CMPX0.0%

DTIL0.0%

EBITDA Margin (TTM)

CMPX0.0%

DTIL-78.0%

Net Margin (TTM)

CMPX0.0%

DTIL-117.0%

FCF Margin (TTM)

CMPXN/A

DTIL-116.3%

Net Income (TTM)

CMPX$-30M

DTIL$-53M

FCF (TTM)

CMPX$-56M

DTIL$-52M

EPS (TTM)

CMPX$0.00

DTIL-$2.04

ROE (TTM)

CMPX-2994.0%

DTIL-9160.0%

ROA (TTM)

CMPX-2635.0%

DTIL-4074.0%

ROIC (TTM)

CMPX-2994.0%

DTIL-6594.0%

Cash

CMPX$35M

DTIL$86M

Debt

CMPX$0

DTIL$22M

Net Cash/Debt

CMPX$35M

DTIL$64M

Current Ratio (TTM)

CMPX11.22x

DTIL12.82x

Quick Ratio (TTM)

CMPX11.15x

DTIL12.26x

Debt/Equity (TTM)

CMPX0.00x

DTIL0.50x

Debt/Assets (TTM)

CMPX0.0%

DTIL0.0%

Interest Coverage (TTM)

CMPXN/A

DTILN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

DTIL0.00x

Beta

CMPX1.07

DTIL1.44

52W Performance

CMPX-74.5%

DTIL17.9%

YTD Performance

CMPX-80.8%

DTIL63.9%

% from 52W High

CMPX-85.6%

DTIL-30.1%

% from 52W Low

CMPX19.7%

DTIL90.4%

Asset Turnover (TTM)

CMPX0.00x

DTIL0.36x

FCF Yield (TTM)

CMPX-31.5%

DTIL-30.2%

Earnings Yield (TTM)

CMPX-16.8%

DTIL-30.4%

Dividend Yield (TTM)

CMPXN/A

DTILN/A

Rule of 40

CMPX0.0

DTIL3,356.7

EV/GP/RG

CMPXN/A

DTILN/A

Ticker research

View CMPX research View DTIL research

Metric	CMPX Compass Therapeutics Inc.	DTIL Precision BioSciences Inc
Market & Valuation
Market Cap	$179M	$173M
Enterprise Value	$143M	$110M
Price	$0.99	$6.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.85x
EV/Sales	0.00x	2.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-2.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	80.94x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	3473.0%
Forward Rev Growth	397.5%	-28.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-78.0%
Net Margin (TTM)	0.0%	-117.0%
FCF Margin (TTM)	N/A	-116.3%
Net Income (TTM)	$-30M	$-53M
FCF (TTM)	$-56M	$-52M
EPS (TTM)	$0.00	-$2.04
ROE (TTM)	-2994.0%	-9160.0%
ROA (TTM)	-2635.0%	-4074.0%
ROIC (TTM)	-2994.0%	-6594.0%
Financial Health
Cash	$35M	$86M
Debt	$0	$22M
Net Cash/Debt	$35M	$64M
Current Ratio (TTM)	11.22x	12.82x
Quick Ratio (TTM)	11.15x	12.26x
Debt/Equity (TTM)	0.00x	0.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.44
52W Performance	-74.5%	17.9%
YTD Performance	-80.8%	63.9%
% from 52W High	-85.6%	-30.1%
% from 52W Low	19.7%	90.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-31.5%	-30.2%
Earnings Yield (TTM)	-16.8%	-30.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,356.7
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View DTIL research

Valuation

P/S Ratio

CMPX

0.00x

DTIL

3.85x

EV/FCF

CMPX

-2.54x

DTIL

-2.09x

Growth & revenue

Revenue Growth TTM

DTIL

3473.0%

Forward Revenue Growth

CMPX

397.5%

DTIL

-28.2%

Profitability & performance

Gross Margin

CMPX

0.0%

DTIL

0.0%

ROE

CMPX

-2994.0%

DTIL

-9160.0%

FCF Yield %

DTIL

-30.2%

CMPX

-31.5%

52-Week Performance

DTIL

17.9%

CMPX

-74.5%

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

DTIL

Precision BioSciences Inc

Market Cap

CMPX$179M

DTIL$173M

Enterprise Value

CMPX$143M

DTIL$110M

Price

CMPX$0.99

DTIL$6.72

P/E Ratio

CMPXN/A

DTILN/A

P/S Ratio

CMPX0.00x

DTIL3.85x

EV/Sales

CMPX0.00x

DTIL2.44x

EV/EBITDA

CMPX0.00x

DTIL0.00x

P/B Ratio

CMPX0.93x

DTIL3.85x

P/FCF Ratio

CMPXN/A

DTILN/A

EV/FCF

CMPX-2.54x

DTIL-2.09x

PEG Ratio

CMPXN/A

DTILN/A

Forward P/E (NTM)

CMPXN/A

DTILN/A

Forward P/S (NTM)

CMPX1.51x

DTIL80.94x

Revenue (TTM)

CMPX$0

DTIL$45M

Revenue Growth (YoY)

CMPXN/A

DTIL3473.0%

Forward Rev Growth

CMPX397.5%

DTIL-28.2%

Gross Margin (TTM)

CMPX0.0%

DTIL0.0%

Operating Margin (TTM)

CMPX0.0%

DTIL0.0%

EBITDA Margin (TTM)

CMPX0.0%

DTIL-78.0%

Net Margin (TTM)

CMPX0.0%

DTIL-117.0%

FCF Margin (TTM)

CMPXN/A

DTIL-116.3%

Net Income (TTM)

CMPX$-30M

DTIL$-53M

FCF (TTM)

CMPX$-56M

DTIL$-52M

EPS (TTM)

CMPX$0.00

DTIL-$2.04

ROE (TTM)

CMPX-2994.0%

DTIL-9160.0%

ROA (TTM)

CMPX-2635.0%

DTIL-4074.0%

ROIC (TTM)

CMPX-2994.0%

DTIL-6594.0%

Cash

CMPX$35M

DTIL$86M

Debt

CMPX$0

DTIL$22M

Net Cash/Debt

CMPX$35M

DTIL$64M

Current Ratio (TTM)

CMPX11.22x

DTIL12.82x

Quick Ratio (TTM)

CMPX11.15x

DTIL12.26x

Debt/Equity (TTM)

CMPX0.00x

DTIL0.50x

Debt/Assets (TTM)

CMPX0.0%

DTIL0.0%

Interest Coverage (TTM)

CMPXN/A

DTILN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

DTIL0.00x

Beta

CMPX1.07

DTIL1.44

52W Performance

CMPX-74.5%

DTIL17.9%

YTD Performance

CMPX-80.8%

DTIL63.9%

% from 52W High

CMPX-85.6%

DTIL-30.1%

% from 52W Low

CMPX19.7%

DTIL90.4%

Asset Turnover (TTM)

CMPX0.00x

DTIL0.36x

FCF Yield (TTM)

CMPX-31.5%

DTIL-30.2%

Earnings Yield (TTM)

CMPX-16.8%

DTIL-30.4%

Dividend Yield (TTM)

CMPXN/A

DTILN/A

Rule of 40

CMPX0.0

DTIL3,356.7

EV/GP/RG

CMPXN/A

DTILN/A

Ticker research

View CMPX research View DTIL research

Metric	CMPX Compass Therapeutics Inc.	DTIL Precision BioSciences Inc
Market & Valuation
Market Cap	$179M	$173M
Enterprise Value	$143M	$110M
Price	$0.99	$6.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.85x
EV/Sales	0.00x	2.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-2.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	80.94x
Revenue & Growth
Revenue (TTM)	$0	$45M
Revenue Growth (YoY)	N/A	3473.0%
Forward Rev Growth	397.5%	-28.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-78.0%
Net Margin (TTM)	0.0%	-117.0%
FCF Margin (TTM)	N/A	-116.3%
Net Income (TTM)	$-30M	$-53M
FCF (TTM)	$-56M	$-52M
EPS (TTM)	$0.00	-$2.04
ROE (TTM)	-2994.0%	-9160.0%
ROA (TTM)	-2635.0%	-4074.0%
ROIC (TTM)	-2994.0%	-6594.0%
Financial Health
Cash	$35M	$86M
Debt	$0	$22M
Net Cash/Debt	$35M	$64M
Current Ratio (TTM)	11.22x	12.82x
Quick Ratio (TTM)	11.15x	12.26x
Debt/Equity (TTM)	0.00x	0.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.44
52W Performance	-74.5%	17.9%
YTD Performance	-80.8%	63.9%
% from 52W High	-85.6%	-30.1%
% from 52W Low	19.7%	90.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-31.5%	-30.2%
Earnings Yield (TTM)	-16.8%	-30.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,356.7
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View DTIL research